Skip to content

Comparison of two video laryngoscopes in patients undergoing tracheal intubation with cervical spine immobilization

Comparision of Two Video Laryngoscope: Guide Channel and Optical Laryngoscope in patients undergoing tracheal intubation with cervical spine immobilization

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014068
Enrollment
60
Registered
2018-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA I and ASA II Age between 18-65 years Mallampati Class I, II and III

Interventions

Intervention1: Comparison between Kingvision videolaryngoscope and Truview laryngoscope: Comparison of two video laryngoscope: guide channel and optical laryngoscope in patients undergoing tracheal in

Sponsors

Artemis Health Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and ASA II Mallampati class I, II and III

Exclusion criteria

Exclusion criteria: Anticipated difficult airway (Mallampati class IV, thyromental distance interincisor gap Presence of risk factor for gastric aspiration e.g. pregnancy. Uncontrolled hypertension and diabetes mellitus, cardiac disease, hepatic and renal impairment. Loose teeth and artificial dentures. BMI > 35. Oral pathology. CNS disorder.

Design outcomes

Primary

MeasureTime frame
IDS score was less in King Vision ® (1.63±1.25) as compared to Truview ® EVO2 (2.03±1.38). But the difference between King Vision and Truview ® EVO2 groups were not statistically significant.Timepoint: During laryngoscopy and intubation

Secondary

MeasureTime frame
Mean duration of intubation was significantly longer in Truview® EVO2 group as compared to King Vision®. Haemodynamic parameters (HR, MAP, Spo2) were comparable in both groups with no statistical significant difference. No major complication in any of the groups.Timepoint: During laryngoscopy and intubation and 5 minutes post intubation.

Countries

India

Contacts

Public ContactDr Rajesh Misra

Artemis Hospitals

naveen2y@hotmail.com9891613461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026